Research and Development
Although GLP/GMP certified, ViruSure can also provide high-quality customized services at the R&D level for your special unmet needs.
In Vitro Potency Studies
The potency of a biopharmaceutical product is key for batch release and for biosimilar comparability assessment.
The recent hygiene requirements to fight the Covid-19 pandemic have highlighted the importance of disinfectants. ViruSure can perform virucidal testing of your agent following the DIN, Robert Koch Institute (RKI) and German Association for the Control of Virus Diseases (DVV) guidelines.
NGS for Quality Control Testing of Biologics
Next generation sequencing (NGS) is a revolutionary technology in the field of biosafety testing and is one of the significant new technologies discussed in the ongoing revision of ICH Q5A. NGS is a method to determine the complete nucleic acid sequence information from a variety of biological samples (cell banks, bulk harvests, cell and gene therapy products, etc.). It can be used for numerous tests like adventitious virus detection, sequence identity confirmation, sterility testing, and the identification of contaminants present in a sample without any prior sequence knowledge.